PubMed:10207061
Annnotations
PMID_GLOBAL
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 235-237 | DiseaseOrPhenotypicFeature | denotes | RA | 0005272|0008383 |
| T3 | 412-414 | DiseaseOrPhenotypicFeature | denotes | RA | 0005272|0008383 |
| T5 | 847-849 | DiseaseOrPhenotypicFeature | denotes | RA | 0005272|0008383 |
| T7 | 1187-1189 | DiseaseOrPhenotypicFeature | denotes | RA | 0005272|0008383 |
| T9 | 2014-2016 | DiseaseOrPhenotypicFeature | denotes | RA | 0005272|0008383 |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-19 | protein | denotes | Retinoid X receptor |
| T2 | 21-24 | protein | denotes | RXR |
| T3 | 74-77 | protein | denotes | RXR |
| T4 | 260-263 | protein | denotes | RAR |
| T5 | 268-311 | protein | denotes | retinoid X receptor (RXR) nuclear receptors |
| T6 | 340-360 | DNA | denotes | DNA target sequences |
| T7 | 364-376 | protein | denotes | heterodimers |
| T8 | 378-385 | protein | denotes | RXR-RAR |
| T9 | 390-400 | protein | denotes | homodimers |
| T10 | 402-409 | protein | denotes | RXR-RXR |
| T11 | 522-556 | protein | denotes | COOH-terminally truncated RARalpha |
| T12 | 596-607 | protein | denotes | RARalpha403 |
| T13 | 649-697 | cell_line | denotes | hematopoietic growth factor-dependent cell lines |
| T14 | 961-979 | cell_type | denotes | MPRO promyelocytes |
| T15 | 999-1012 | protein | denotes | interleukin-3 |
| T16 | 1014-1018 | protein | denotes | IL-3 |
| T17 | 1042-1051 | cell_type | denotes | EML cells |
| T18 | 1123-1126 | protein | denotes | RXR |
| T19 | 1132-1135 | protein | denotes | RAR |
| T20 | 1238-1256 | protein | denotes | truncated RARalpha |
| T21 | 1340-1343 | protein | denotes | RXR |
| T22 | 1369-1372 | protein | denotes | RAR |
| T23 | 1440-1458 | cell_type | denotes | MPRO promyelocytes |
| T24 | 1518-1539 | DNA | denotes | DNA response elements |
| T25 | 1557-1577 | protein | denotes | RAR-RXR heterodimers |
| T26 | 1590-1608 | protein | denotes | RXR-RXR homodimers |
| T27 | 1615-1618 | protein | denotes | RXR |
| T28 | 1650-1653 | protein | denotes | RAR |
| T29 | 1736-1763 | protein | denotes | RXR-RARalpha403 heterodimer |
| T30 | 1812-1821 | cell_type | denotes | EML cells |
| T31 | 1844-1847 | protein | denotes | RXR |
| T32 | 1900-1904 | protein | denotes | IL-3 |
| T33 | 1928-1937 | cell_type | denotes | EML cells |
| T34 | 1945-1964 | cell_type | denotes | granulocyte lineage |
| T35 | 1987-2012 | DNA | denotes | RAR-RXR response elements |
| T36 | 2034-2042 | protein | denotes | RARalpha |
| T37 | 2105-2114 | cell_type | denotes | EML cells |
| T38 | 2159-2170 | protein | denotes | coactivator |
| T39 | 2194-2230 | protein | denotes | histone deacetylase (HDAC) inhibitor |
| T40 | 2267-2293 | DNA | denotes | RXR-RAR reporter construct |
| T41 | 2313-2322 | cell_type | denotes | EML cells |
| T42 | 2348-2366 | cell_type | denotes | MPRO promyelocytes |
| T43 | 2399-2434 | protein | denotes | HDAC-containing repressor complexes |
| T44 | 2477-2499 | cell_type | denotes | hematopoietic lineages |
| T45 | 2553-2581 | protein | denotes | RXR-RARalpha403 heterodimers |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-183 | Sentence | denotes | Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha403 heterodimers is developmentally regulated during myeloid differentiation. |
| S2 | 184-411 | Sentence | denotes | The multiple biologic activities of retinoic acid (RA) are mediated through RAR and retinoid X receptor (RXR) nuclear receptors that interact with specific DNA target sequences as heterodimers (RXR-RAR) or homodimers (RXR-RXR). |
| S3 | 412-781 | Sentence | denotes | RA receptor activation appears critical to regulating important aspects of hematopoiesis, since transducing a COOH-terminally truncated RARalpha exhibiting dominant-negative activity (RARalpha403) into normal mouse bone marrow generates hematopoietic growth factor-dependent cell lines frozen at the multipotent progenitor (EML) or committed promyelocyte (MPRO) stages. |
| S4 | 782-1088 | Sentence | denotes | Nevertheless, relatively high, pharmacological concentrations of RA (1 to 10 microM) overcome these differentiation blocks and induce terminal granulocytic differentiation of the MPRO promyelocytes while potentiating interleukin-3 (IL-3)-induced commitment of EML cells to the granulocyte/monocyte lineage. |
| S5 | 1089-1305 | Sentence | denotes | In the present study, we utilized RXR- and RAR-specific agonists and antagonists to determine how RA overcomes the dominant-negative activity of the truncated RARalpha in these different myeloid developmental stages. |
| S6 | 1306-1609 | Sentence | denotes | Unexpectedly, we observed that an RXR-specific, rather than an RAR-specific, agonist induces terminal granulocytic differentiation of MPRO promyelocytes, and this differentiation is associated with activation of DNA response elements corresponding to RAR-RXR heterodimers rather than RXR-RXR homodimers. |
| S7 | 1610-1764 | Sentence | denotes | This RXR agonist activity is blocked by RAR-specific antagonists, suggesting extensive cross-talk between the partners of the RXR-RARalpha403 heterodimer. |
| S8 | 1765-2013 | Sentence | denotes | In contrast, in the more immature, multipotent EML cells we observed that this RXR-specific agonist is inactive either in potentiating IL-3-mediated commitment of EML cells to the granulocyte lineage or in transactivating RAR-RXR response elements. |
| S9 | 2014-2180 | Sentence | denotes | RA-triggered GALdbd-RARalpha hybrid activity in these cells indicates that the multipotent EML cells harbor substantial nuclear hormone receptor coactivator activity. |
| S10 | 2181-2648 | Sentence | denotes | However, the histone deacetylase (HDAC) inhibitor trichostatin A readily activates an RXR-RAR reporter construct in the multipotent EML cells but not in the committed MPRO promyelocytes, indicating that differences in HDAC-containing repressor complexes in these two closely related but distinct hematopoietic lineages might account for the differential activation of the RXR-RARalpha403 heterodimers that we observed at these different stages of myeloid development. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 56-122 | NP | denotes | dominant-negative RXR-retinoic acid receptor alpha403 heterodimers |
| C2 | 220-238 | NP | denotes | retinoic acid (RA) |
| C3 | 260-311 | NP | denotes | RAR and retinoid X receptor (RXR) nuclear receptors |
| C4 | 312-316 | NP | denotes | that |
| C5 | 364-386 | NP | denotes | heterodimers (RXR-RAR) |
| C6 | 390-410 | NP | denotes | homodimers (RXR-RXR) |
| C7 | 847-849 | NP | denotes | RA |
| C8 | 916-979 | NP | denotes | terminal granulocytic differentiation of the MPRO promyelocytes |
| C9 | 1042-1051 | NP | denotes | EML cells |
| C10 | 1187-1189 | NP | denotes | RA |
| C11 | 1399-1458 | NP | denotes | terminal granulocytic differentiation of MPRO promyelocytes |
| C12 | 1464-1484 | NP | denotes | this differentiation |
| C13 | 1557-1577 | NP | denotes | RAR-RXR heterodimers |
| C14 | 1590-1608 | NP | denotes | RXR-RXR homodimers |
| C15 | 1732-1763 | NP | denotes | the RXR-RARalpha403 heterodimer |
| C16 | 1928-1937 | NP | denotes | EML cells |
| C17 | 2062-2073 | NP | denotes | these cells |
| C19 | 2549-2581 | NP | denotes | the RXR-RARalpha403 heterodimers |
| C18 | 2518-2581 | NP | denotes | the differential activation of the RXR-RARalpha403 heterodimers |
| C20 | 2582-2586 | NP | denotes | that |
| R1 | C4 | C3 | coref-relat | that,RAR and retinoid X receptor (RXR) nuclear receptors |
| R2 | C7 | C2 | coref-ident | RA,retinoic acid (RA) |
| R3 | C10 | C7 | coref-ident | RA,RA |
| R4 | C11 | C8 | coref-ident | terminal granulocytic differentiation of MPRO promyelocytes,terminal granulocytic differentiation of the MPRO promyelocytes |
| R5 | C12 | C11 | coref-ident | this differentiation,terminal granulocytic differentiation of MPRO promyelocytes |
| R6 | C13 | C5 | coref-ident | RAR-RXR heterodimers,heterodimers (RXR-RAR) |
| R7 | C14 | C6 | coref-ident | RXR-RXR homodimers,homodimers (RXR-RXR) |
| R8 | C15 | C1 | coref-ident | the RXR-RARalpha403 heterodimer,dominant-negative RXR-retinoic acid receptor alpha403 heterodimers |
| R9 | C16 | C9 | coref-ident | EML cells,EML cells |
| R10 | C17 | C16 | coref-ident | these cells,EML cells |
| R11 | C19 | C15 | coref-ident | the RXR-RARalpha403 heterodimers,the RXR-RARalpha403 heterodimer |
| R12 | C20 | C18 | coref-relat | that,the differential activation of the RXR-RARalpha403 heterodimers |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-19 | protein_molecule | denotes | Retinoid X receptor |
| T2 | 21-24 | protein_molecule | denotes | RXR |
| T3 | 74-77 | protein_molecule | denotes | RXR |
| T4 | 159-182 | other_name | denotes | myeloid differentiation |
| T5 | 188-216 | other_name | denotes | multiple biologic activities |
| T6 | 220-233 | other_organic_compound | denotes | retinoic acid |
| T7 | 235-237 | other_organic_compound | denotes | RA |
| T8 | 260-263 | protein_family_or_group | denotes | RAR |
| T9 | 268-289 | protein_molecule | denotes | retinoid X receptor ( |
| T10 | 289-292 | protein_molecule | denotes | RXR |
| T11 | 340-360 | DNA_domain_or_region | denotes | DNA target sequences |
| T12 | 364-376 | protein_complex | denotes | heterodimers |
| T13 | 378-385 | protein_complex | denotes | RXR-RAR |
| T14 | 390-400 | protein_complex | denotes | homodimers |
| T15 | 402-409 | protein_complex | denotes | RXR-RXR |
| T16 | 412-414 | other_organic_compound | denotes | RA |
| T17 | 487-500 | other_name | denotes | hematopoiesis |
| T18 | 522-556 | protein_molecule | denotes | COOH-terminally truncated RARalpha |
| T19 | 596-607 | protein_molecule | denotes | RARalpha403 |
| T20 | 614-638 | tissue | denotes | normal mouse bone marrow |
| T21 | 649-697 | cell_line | denotes | hematopoietic growth factor-dependent cell lines |
| T22 | 813-843 | other_name | denotes | pharmacological concentrations |
| T23 | 847-849 | other_organic_compound | denotes | RA |
| T24 | 916-953 | other_name | denotes | terminal granulocytic differentiation |
| T25 | 961-979 | cell_type | denotes | MPRO promyelocytes |
| T26 | 999-1012 | protein_molecule | denotes | interleukin-3 |
| T27 | 1014-1018 | protein_molecule | denotes | IL-3 |
| T28 | 1042-1051 | cell_type | denotes | EML cells |
| T29 | 1123-1126 | protein_molecule | denotes | RXR |
| T30 | 1132-1135 | protein_family_or_group | denotes | RAR |
| T31 | 1145-1153 | other_organic_compound | denotes | agonists |
| T32 | 1158-1169 | other_organic_compound | denotes | antagonists |
| T33 | 1187-1189 | other_organic_compound | denotes | RA |
| T34 | 1204-1230 | other_name | denotes | dominant-negative activity |
| T35 | 1238-1256 | protein_family_or_group | denotes | truncated RARalpha |
| T36 | 1276-1304 | other_name | denotes | myeloid developmental stages |
| T37 | 1340-1343 | protein_molecule | denotes | RXR |
| T38 | 1369-1372 | protein_family_or_group | denotes | RAR |
| T39 | 1399-1436 | other_name | denotes | terminal granulocytic differentiation |
| T40 | 1440-1458 | cell_type | denotes | MPRO promyelocytes |
| T41 | 1518-1539 | DNA_domain_or_region | denotes | DNA response elements |
| T42 | 1557-1577 | protein_complex | denotes | RAR-RXR heterodimers |
| T43 | 1590-1597 | protein_complex | denotes | RXR-RXR |
| T44 | 1615-1618 | protein_molecule | denotes | RXR |
| T45 | 1650-1653 | protein_family_or_group | denotes | RAR |
| T46 | 1736-1739 | protein_molecule | denotes | RXR |
| T47 | 1739-1751 | protein_molecule | denotes | -RARalpha403 |
| T48 | 1812-1821 | cell_type | denotes | EML cells |
| T49 | 1844-1847 | protein_molecule | denotes | RXR |
| T50 | 1900-1904 | protein_molecule | denotes | IL-3 |
| T51 | 1928-1937 | cell_type | denotes | EML cells |
| T52 | 1945-1964 | cell_type | denotes | granulocyte lineage |
| T53 | 1987-2012 | DNA_family_or_group | denotes | RAR-RXR response elements |
| T54 | 2014-2016 | other_organic_compound | denotes | RA |
| T55 | 2034-2042 | protein_molecule | denotes | RARalpha |
| T56 | 2105-2114 | cell_type | denotes | EML cells |
| T57 | 2134-2158 | other_name | denotes | nuclear hormone receptor |
| T58 | 2159-2170 | protein_family_or_group | denotes | coactivator |
| T59 | 2194-2230 | protein_family_or_group | denotes | histone deacetylase (HDAC) inhibitor |
| T60 | 2231-2245 | other_organic_compound | denotes | trichostatin A |
| T61 | 2267-2274 | protein_complex | denotes | RXR-RAR |
| T62 | 2313-2322 | cell_type | denotes | EML cells |
| T63 | 2348-2366 | cell_type | denotes | MPRO promyelocytes |
| T64 | 2399-2434 | protein_complex | denotes | HDAC-containing repressor complexes |
| T65 | 2477-2499 | cell_type | denotes | hematopoietic lineages |
| T66 | 2553-2581 | protein_complex | denotes | RXR-RARalpha403 heterodimers |
| T67 | 2628-2647 | other_name | denotes | myeloid development |